H1 FY22 Results Presentation

Strong growth in operating cashflows A$m H1 FY22 H1 FY21 Growth Statutory operating cash flow 80.0 111.7 (28%) Add: IPO deal costs in operating cash flow 20.9 (0.0) Add: Net finance costs paid (0.0) (0.0) Add: Net income taxes paid 37.5 5.7 Pro forma operating cash flow¹ 138.4 117.4 18% Pro forma EBITDA² 138.8 119.1 17% Pro forma EBITDA cash conversion³ 100% 98% Statutory cash flow Operating cash flow Investing cash flow Financing cash flow Net increase / (decrease) in cash Opening cash (including FX differences) Closing cash 80.0 111.7 (113.6) (31.1) 148.1 (46.4) 114.5 34.2 106.8 221.3 28.9 63.1 . Pro forma operating cashflow up 18% to $138.4m Underpinned by EBITDA growth in H1 FY22 • Investing cashflow of $113.6m supports growth strategy Acquisitions of Generation Health, DWFS, Early Start Australia, MyIntegra and Mobility - $76.4m Capex driven by Restart mobilisation, IT fleet and security upgrades - $37.2m Financing cash flows of $148.1m Includes proceeds of $343.5m from the IPO and debt repayments of $161.9m Interest payments down $10.6m following July 2021 debt refinance, IPO and debt repayment (1) pro forma operating cash (statutory operating cash adding back cash income tax paid, net finance costs and one-off IPO advisor fees) (2) Earnings before interest, tax, depreciation and amortization, refer slide 24 for a reconciliation of pro forma EBITDA APM 14 |H1 FY22 Results Presentation (3) Cash conversion reflects pro forma operating cash (statutory operating cash adding back cash income tax paid, net finance costs and one-off IPO advisor fees) divided by pro forma EBITDA. enabling better lives

View entire presentation